{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:19Z","timestamp":1761058159896},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00686912","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T17:13:11Z","timestamp":1101661991000},"page":"S14-S17","source":"Crossref","is-referenced-by-count":4,"title":["Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis"],"prefix":"10.1007","volume":"35","author":[{"given":"Hiroaki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0090-4295(85)90532-1","volume":"25","author":"DE Hill","year":"1985","unstructured":"Hill DE, Ford KS, Soloway MS (1985) Radical cystectomy and adjuvant chemotherapy. Urology 25:151","journal-title":"Urology"},{"issue":"Suppl","key":"CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00686950","volume":"30","author":"T Kotake","year":"1992","unstructured":"Kotake T, Akaza H, Isaka S, Kagawa S, Koiso K, Machida T, Maru A, Matsumura Y, Miyagawa I, Niijima T, Obata K, Ohashi Y, Ohe H, Ohi Y, Okajima E, Sakata Y, Shimazaki J, Tashiro K, Togashi M, Ueda T, Uyama T, Yoshikawa K, Japanese Urological Cancer Research Group for Adriamycin (1992) Evaluation of systemic chemotherapy with methotrexate, vinblastine, Adriamycin, and cisplatin for advanced bladder cancer. Cancer Chemother Pharmacol 30 [Suppl]:S85","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19900115)65:2<207::AID-CNCR2820650204>3.0.CO;2-2","volume":"65","author":"RJ Miller","year":"1990","unstructured":"Miller RJ, Bahnson RR, Banner B, Ernstoff MS, O'Donnell W (1990) Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for locally advanced transitional cell carcinoma of bladder. Cancer 65:207","journal-title":"Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1464-410X.1989.tb06008.x","volume":"64","author":"H Sher","year":"1989","unstructured":"Sher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershau D, Renter V, Curley T, Vaughan ED, Whitmore WF Jr, Yagoda A (1989) Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. Br J Urol 64:250","journal-title":"Br J Urol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-5347(17)38368-4","volume":"145","author":"DG Skinner","year":"1991","unstructured":"Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459","journal-title":"J Urol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)48996-8","volume":"133","author":"CN Sternberg","year":"1985","unstructured":"Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403","journal-title":"J Urol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5347(17)42494-3","volume":"139","author":"CN Sternberg","year":"1988","unstructured":"Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HM, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, Geller N, Hollander PS, Lipperman R, Fair WR, Whitmore WF Jr (1988) M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139:461","journal-title":"J Urol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7","volume":"64","author":"CN Sternberg","year":"1989","unstructured":"Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg L, Rosado K, Smart T, Lin S, Penengerg D, Fair W, Whitmore WF (1989) Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional-cell carcinoma of the urothelium. Cancer 64:2448","journal-title":"Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-5347(17)36578-3","volume":"148","author":"M Stockle","year":"1992","unstructured":"Stockle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber CH, Hohenfelliner R (1992) Advanced bladder cancer (stage pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148:302","journal-title":"J Urol"},{"issue":"Suppl","key":"CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00686943","volume":"30","author":"Y Uekado","year":"1992","unstructured":"Uekado Y, Hirano A, Shinka T, Ohkawa T (1992) Results of adjuvant chemotherapy for invasive uroepithelial cancer. Cancer Chemother Pharmacol 30 [Suppl]:S55","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR11","first-page":"519","volume":"38","author":"S Yamashita","year":"1992","unstructured":"Yamashita S, Taniguchi K, Morimitsu H, Suzu H, Kanetake H, Saito Y (1992) Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer. Acta Urol Jpn 38:519","journal-title":"Acta Urol Jpn"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686912\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:11:08Z","timestamp":1554459068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":11,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00686912"],"URL":"https:\/\/doi.org\/10.1007\/bf00686912","relation":{},"ISSN":["0943-9404","1432-0843"],"issn-type":[{"value":"0943-9404","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}